Video Experimental Relacionado
Updated: Jan 13, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Factor B del complemento de origen mucoso modula la respuesta del huésped a la colitis
Aayusha Thapa1, Aasritha Nallapu1, Nnenna Mougboh1
1Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA, USA.
La producción local de Factor B del Complemento (CFB) en el intestino mitiga la colitis. El CFB derivado del intestino, no los niveles circulantes, es crucial para la homeostasis intestinal y la defensa de la mucosa.
Más Videos Relacionados
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Videos de Conceptos Relacionados
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Complement System
Regulation of Hematopoietic Stem Cells
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD